SD Biosensor Inc (137310) — Financial Flexibility Index
SD Biosensor Inc (137310) has a Financial Flexibility Index of 0.03x as of September 2025. Free cash flow of ₩27.53 Billion (operating CF ₩14.90 Billion minus capex ₩12.64 Billion) represents 0% of total liabilities (₩914.08 Billion). Check SD Biosensor Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
SD Biosensor Inc Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for SD Biosensor Inc across 6 annual periods. See SD Biosensor Inc (137310) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for SD Biosensor Inc (2019–2024)
Year-by-year free cash flow to debt coverage for SD Biosensor Inc. For the full company profile including market capitalisation, see 137310 company net worth.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.25x | ₩237.43 Billion | ₩156.53 Billion | ₩956.18 Billion | ▲ +343.5% |
| 2023 | -0.10x | ₩-97.63 Billion | ₩-242.32 Billion | ₩957.28 Billion | ▼ -102.7% |
| 2022 | 3.78x | ₩1.19 Trillion | ₩890.23 Billion | ₩315.14 Billion | ▲ +112.6% |
| 2021 | 1.78x | ₩1.42 Trillion | ₩1.23 Trillion | ₩801.72 Billion | ▲ +127.4% |
| 2020 | 0.78x | ₩550.29 Billion | ₩495.38 Billion | ₩704.10 Billion | ▲ +326.6% |
| 2019 | 0.18x | ₩5.83 Billion | ₩-1.62 Billion | ₩31.80 Billion | — |